Dr. Mohammed Abdul Muneer is an Associate Professor with a Ph.D. in Molecular Biology and extensive experience in translational neuroscience, focusing on neuroimmunology of traumatic brain injury (TBI), and alcohol-induced neurovascular dysfunction. His research explores the cellular and molecular mechanisms of neuroinflammation, neurodegeneration, and blood-brain barrier disruption in TBI and alcohol use disorder. Dr. Muneerâs research has been published in more than 50 high-impact peer-reviewed journals, including The Journal of Neuroscience, Molecular Neurodegeneration, Brain Behavior and Immunity, eNeuro, etc. His work is supported by multiple extramural grants, notably: an NIH R01 grant ($2.21M; awarded in 2024), an NIH R21 grant ($470,000; awarded in 2023), and three grants from the New Jersey Department of Health (in 2016, 2018, and 2019). He has mentored several postdoctoral fellows, graduate and undergraduate students, and trainees at various academic levels, and advised seven masterâs theses. Dr. Muneer serves on grant review panels for the NIH, Department of Defense (DoD), and national funding agencies of Israel and Poland. He is an active peer reviewer for more than 20 scientific journals and has evaluated Ph.D. theses for various universities. In addition, he holds roles as a Research Council Member and Advisory Board Member at multiple academic institutions, and he has served as an IACUC committee member for 9 years. has served as an IACUC committee member for 9 years. He is also an Editorial Board member in different journals such as the Journal of Spinal Cord Medicine, Antioxidants, Frontiers in Genetics, Trauma Cases and Reviews, JSM Brain Science, and Topical Advisory Panel in âAntioxidantsâ.